Biblio

Author Title [ Type(Asc)] Year
Filters: Author is Wang, Mei-Fang  [Clear All Filters]
Journal Article
You H, Zhang Y-Z, Lai H-L, Li D, Liu Y-Q, Li R-Z, Khan I, Hsiao WWen-Lun, Duan F-G, Fan X-X, et al. Prognostic significance of tumor poliovirus receptor and CTLA4 expression in patients with surgically resected non-small-cell lung cancer. J Cancer Res Clin Oncol. 2020.
Yang X-X, Xu X, Wang M-F, Xu H-Z, Peng X-C, Han N, Yu T-T, Li L-G, Li Q-R, Chen X, et al. A nanoreactor boosts chemodynamic therapy and ferroptosis for synergistic cancer therapy using molecular amplifier dihydroartemisinin. J Nanobiotechnology. 2022;20(1):230.
Yu T-T, Sang X-Y, Han N, Peng X-C, Li Q-R, Xu X, Xiao R-C, Xu H-Z, Chen X, Wang M-F, et al. Macrophages mediated delivery of chlorin e6 and treatment of lung cancer by photodynamic reprogramming. Int Immunopharmacol. 2021;100:108164.
Li Q-R, Xu H-Z, Xiao R-C, Liu B, Ma T-Q, Yu T-T, Li L-G, Wang M-F, Zhao L, Chen X, et al. Laser-triggered intelligent drug delivery and anti-cancer photodynamic therapy using platelets as the vehicle. Platelets. 2023;34(1):2166677.
Yu T-T, Peng X-C, Wang M-F, Han N, Xu H-Z, Li Q-R, Li L-G, Xu X, Ma Q-L, Liu B, et al. Harnessing chlorin e6 loaded by functionalized iron oxide nanoparticles linked with glucose for target photodynamic therapy and improving of the immunogenicity of lung cancer. J Cancer Res Clin Oncol. 2022.
Han N, Li L-G, Peng X-C, Ma Q-L, Yang Z-Y, Wang X-Y, Li J, Li Q-R, Yu T-T, Xu H-Z, et al. Ferroptosis triggered by dihydroartemisinin facilitates chlorin e6 induced photodynamic therapy by inhibiting GPX4 and enhancing ROS. Eur J Pharmacol. 2022:174797.
Li L-G, Hu J, Han N, Chen N-N, Yu T-T, Ren T, Xu H-Z, Peng X-C, Li X-Y, Ma T-Q, et al. Dihydroartemisinin-driven TOM70 inhibition leads to mitochondrial destabilization to induce pyroptosis against lung cancer. Phytother Res. 2024.
Ma Q-L, Shen M-O, Han N, Xu H-Z, Peng X-C, Li Q-R, Yu T-T, Li L-G, Xu X, Liu B, et al. Chlorin e6 mediated photodynamic therapy triggers resistance through ATM-related DNA damage response in lung cancer cells. Photodiagnosis Photodyn Ther. 2021:102645.
Yang Z-Y, Li L-G, Xiong Y-L, Chen N-N, Yu T-T, Li H-T, Ren T, You H, Wang X, Li T-F, et al. Cepharanthine synergizes with photodynamic therapy for boosting ROS-driven DNA damage and suppressing MTH1 as a potential anti-cancer strategy. Photodiagnosis Photodyn Ther. 2023:103917.